Figure 2

Cost-effectiveness of cardiovascular disease prevention. Graph shows cost-effectiveness of current practice, cost-effectiveness of existing single risk factor-based guidelines, and cost-effectiveness of prevention targeted at ≥15%, ≥10% and ≥5% absolute risk groups (NB. The scatter of points for each intervention reflects the uncertainty in the cost-effectiveness result. All points that fall under the threshold line, which is illustrated here at $50,000/QALY, are considered ‘cost-effective’).